Heparin-coated CPB-sets increase biocompatibility and reduce endothelial cell damage in pigs.
Bagge
L
L
Dept of Thoracic Surgery, University Hospital, Uppsala, Sweden.
Thelin
S
S
Hultman
J
J
Nilsson
L
L
Thorelius
J
J
Hillström
P A
PA
D000818:Animals; D001672:Biocompatible Materials / Q000737:chemistry*; D002315:Cardiopulmonary Bypass / Q000295:instrumentation*; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000473:pathology; D005169:Factor VIII / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects; D006461:Hemolysis / Q000187:drug effects; D006493:Heparin / Q000737:chemistry / Q000627:therapeutic use*; D007958:Leukocyte Count / Q000187:drug effects; D010107:Oxygenators, Membrane; D010973:Platelet Adhesiveness / Q000187:drug effects; D010976:Platelet Count / Q000187:drug effects; D013499:Surface Properties; D013552:Swine; D014914:Whole Blood Coagulation Time; D014841:von Willebrand Factor / Q000032:analysis
D001672:Biocompatible Materials; D014841:von Willebrand Factor; D005169:Factor VIII; D006493:Heparin